Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 11.

Brandtner, H; Monticelli, F C; Meyer, H J; Biebl, A; Budka, H (2016). Fatal cerebral haemorrhage in a hypertensive seven-year-old boy. Journal of the Royal Society of Medicine open, 7(9):1-4.

Assar, H; Topakian, R; Weis, S; Rahimi, J; Trenkler, J; Hoftberger, R; Aboulenein-Djamshidian, F; Strobel, T; Budka, H; Yull, H; Head, M W; Ironside, J W; Kovacs, G G (2015). A case of variably protease-sensitive prionopathy treated with doxycyclin. Journal of Neurology, Neurosurgery, and Psychiatry, 86(7):816-818.

Budka, H; Kovacs, G G (2013). Gerstmann–Sträussler–Scheinker Disease. In: Maloy, Stanley; Hughes, Kelly. Brenner's Encyclopedia of Genetics, 2nd Edition. New York: Elsevier B.V., 327-329.

Deubelbeiss, A N; Trachsel, C; Bachli, E B; Kuffer, A; Budka, H; Eniseyskiy, P; Zimmermann, H; Wallace, R M; Farley, S; Zanoni, R G (2013). Imported human rabies in Switzerland, 2012: a diagnostic conundrum. Journal of Clinical Virology, 57(2):178-181.

Schippling, S; Kempf, C; Büchele, F; Jelcic, I; Bozinov, O; Bont, A; Linnebank, M; Sospedra, M; Weller, M; Budka, H; Martin, R (2013). JCV granule cell neuronopathy and GCN-IRIS under natalizumab treatment. Annals of Neurology, 74(4):622-626.

Noerrung, B; Collins, D; Budka, H; Hugas, M (2012). Risk assessment of biological hazards for consumer protection. EFSA Journal:1-8.

Ladogana, A; Puopolo, M; Croes, E A; Budka, H; Jarius, C; Collins, S; Klug, G M; Sutcliffe, T; Giulivi, A; Alperovitch, A; Delasnerie-Laupretre, N; Brandel, J-P; Poser, S; Kretzschmar, H A; Rietveld, I; Mitrova, E; Cuesta, J de Pedro; Martinez-Martin, P; Glatzel, M; Aguzzi, A; Knight, R; Ward, H; Pocchiari, M; van Duijn, C M; Will, R G; Zerr, I (2005). Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology, 64(9):1586-1591.

Pocchiari, M; Puopolo, M; Croes, E A; Budka, H; Gelpi, E; Collins, S; Lewis, V; Sutcliffe, T; Guilivi, A; Delasnerie-Laupretre, N; Brandel, J-P; Alperovitch, A; Zerr, I; Poser, S; Kretzschmar, H A; Ladogana, A; Rietvald, I; Mitrova, E; Martinez-Martin, P; de Pedro-Cuesta, J; Glatzel, M; Aguzzi, A; Cooper, S; Mackenzie, J; van Duijn, C M; Will, R G (2004). Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain: A Journal of Neurology, 127(10):2348-2359.

Kovacs, G G; Lindeck-Pozza, E; Chimelli, L; Araújo, A Q C; Gabbai, A A; Ströbel, T; Glatzel, M; Aguzzi, A; Budka, H (2004). Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle. Annals of Neurology, 55(1):121-125.

Hainfellner, J A; Voigtländer, T; Ströbel, T; Mazal, P R; Maddalena, A S; Aguzzi, A; Budka, H (2001). Fibroblasts can express glial fibrillary acidic protein (GFAP) in vivo. Journal of Neuropathology and Experimental Neurology, 60(5):449-461.

Budka, H; Aguzzi, A; Brown, P; Brucher, J M; Bugiani, O; Collinge, J; Diringer, H; Gullotta, F; Haltia, M; Hauw, J J; Ironside, J W; Kretzschmar, H A; Lantos, P L; Masullo, C; Pocchiari, M; Schlote, W; Tateishi, J; Will, R G (1996). [Consensus report: tissue handling in suspected Creutzfeldt-Jakob disease and other spongiform encephalopathies (prion diseases) in the human. European Union Biomed-1 Concerted Action]. Der Pathologe, 17(2):171-175.

This list was generated on Fri Oct 20 15:46:54 2017 CEST.